logo
Trump reaches agreement with E.U. to impose 15% tariff, with exceptions for key industries

Trump reaches agreement with E.U. to impose 15% tariff, with exceptions for key industries

Yahoo21 hours ago
President Donald Trump on Sunday announced a trade agreement with the European Union that would set tariffs at 15%, ending what had been months of uncertainty surrounding trade with the United States' largest trade partner.
The tariff rate is a reduction from the 30% that Trump threatened on July 12 and the 20% he said he would impose on April 2.
Announcing the agreement, Trump said the E.U. will not impose a tariff on U.S. imports. He added this agreement was 'satisfactory to both sides.'
Potentially more tariffs on the way
European Commission President Ursula von der Leyen said Sunday alongside Trump that the pact 'will bring stability. It will bring predictability. That's very important for our businesses on both sides of the Atlantic.'
However, Trump said 50% tariffs on steel would remain unchanged and more tariffs could still be on the way for pharmaceutical products, which Ireland is one of the top sources of. Trump recently threatened 200% tariffs on pharma goods.
In the meeting with von der Leyen, Commerce Secretary Howard Lutnick said semiconductor tariffs could also be announced in the coming weeks.
Outlining parts of the agreement, Trump said "the European Union is going to agree to purchase from the United States $750 billion worth of energy." He said the E.U. would also invest $600 billion into the United States. It was not immediately clear what form that investment would take or over what time period it would be deployed.
Trump added that E.U. nations will also be purchasing "a vast amount of military equipment," though a definitive purchase amount was not yet set. The European Commission has been bulking up its military supplies but has been focused on buying primarily from European companies so far.
Trump said this arrangement would lead to the "opening up of all of the European countries, which I think I could say were essentially closed." However, the E.U. buys hundreds of billions of dollars in U.S. goods each year. In 2024, that value was nearly $400 billion.
The agreement appears to closely mirror the trade agreement announced with Japan on Tuesday, under which Japanese imports will face a 15% import duty, which was also lower than Trump earlier threatened.
In a press briefing after the meeting with Trump, von der Leyen said that the 15% tariff would not stack on top of any other tariffs already in place. She said the U.S. and E.U. have both agreed to apply zero tariffs to a number of categories of imports: all aircraft and component parts, certain chemicals, generic pharmaceuticals, semiconductor equipment and some agricultural products.
'We will replace Russian gas and oil by significant purchases of U.S. [liquified natural gas], oil, and nuclear fuels,' she said. Von der Leyen said she estimates the union will buy $250 billion worth of the energy products per year over the course of a three-year period.
'Fifteen percent is not to be underestimated but it is the best we could get,' she added of the still high rate of duties that exports from the 27 European countries will face. 'Fifteen percent is certainly a challenge for some, but we should not forget it keeps access to the American market.'
She described the meeting with Trump as 'very difficult because we started far apart from each other.' In the end, she said it was 'good and satisfactory.'
But last year, the average U.S. tariff on imports from the European Union was just 1.2%, according to Capital Economics' chief Europe economist.
Ireland's prime minister said in a post on X that he welcomed the deal but "it does mean that there will now be higher tariffs than there have been and this will have an impact on trade between the EU and US, making it more expensive and more challenging."
Germany's prime minister responded by saying, "A trade conflict has been averted that would have hit the export-oriented German economy hard. This is especially true for the automotive industry, where the current tariffs will be almost halved from 27.5% to 15%. This is precisely where the rapid reduction of tariffs is of utmost importance."
The European Union has been in active negotiations with Lutnick and U.S. Trade Representative Jamieson Greer for weeks and had believed it was extremely close to a deal before Trump suddenly fired off a letter on Truth Social saying he would hike tariffs to 30%. The E.U.'s top trade negotiator made multiple trips across the Atlantic to meet with his U.S. counterparts and was set to speak by phone with Lutnick again Wednesday, according to a spokesperson for the E.U.
'Imposing 30% tariffs on E.U. exports would disrupt essential transatlantic supply chains, to the detriment of businesses, consumers and patients on both sides of the Atlantic,' von der Leyen said after Trump's July letter.
Immediately after the letter, the E.U. said it would continue working toward an agreement of some type by the new deadline of Aug. 1. But the bloc continued to simultaneously prepare an extensive list of U.S. products against which it could apply retaliatory tariffs if an agreement weren't reached amid fears that Trump could end talks.
Some of those products included Boeing aircraft, U.S. vehicles and imports from politically sensitive states such as bourbon from Kentucky and soybeans from Louisiana. At the time of the announcement, the E.U. had about $100 billion worth of retaliatory tariffs ready to deploy.
Agricultural and business groups had warned that 30% tariffs on the European Union could dramatically impact the price and availability of wines, cheeses and pasta, and called the proposed levy 'incomprehensible.'
Cars and other vehicles produced in the E.U. could still face increased prices. 'The costs for our companies have already reached the billions — and with each passing day, the total continues to grow,' the German auto trade group VDA told NBC News in a statement on July 14.
The 27 countries of the European Union are the United States' largest trading partner — its $605 billion worth of imports into the U.S. surpass Mexico, Canada and even China. The most valuable category of imports in 2024 was drugs and pharmaceuticals primarily from Ireland, followed by autos, aircraft and other heavy machinery from nations such as France and Germany.
Trump has separately threatened to impose a 200% tariff on any drugs imported into the U.S., though it would not be applied for at least 18 months. It was unclear if the deal with the E.U. would prevent that.
This article was originally published on NBCNews.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Russia's Medvedev says Trump's 'ultimatum' could lead to war
Russia's Medvedev says Trump's 'ultimatum' could lead to war

Yahoo

time10 minutes ago

  • Yahoo

Russia's Medvedev says Trump's 'ultimatum' could lead to war

(Reuters) -Former Russian President Dmitry Medvedev said in a post on X on Monday that U.S. President Donald Trump was playing "the ultimatum game" with Russia, and that such an approach could lead to a war involving the United States. Medvedev wrote: "Each new ultimatum is a threat and a step towards war. Not between Russia and Ukraine, but with (Trump's) own country." Trump said on Monday that he was disappointed in Russian President Vladimir Putin's failure to end the war in Ukraine, and that he was reducing a deadline to agree a peace settlement from 50 days to 10 or 12. (Writing by Felix Light; Editing by Jan Harvey)

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

Yahoo

time10 minutes ago

  • Yahoo

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

By Bhanvi Satija (Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday. The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said. Pharmaceuticals had historically been exempt from duties. Medicines are the largest European exports to the United States by value and the EU accounts for about 60% of all pharmaceutical imports to the U.S. On Sunday, European officials said that a bilateral trade deal for an across-the-board 15% tariff included pharmaceuticals, except for some generic drugs, which would be subject to no tariffs. The U.S. has been conducting a national security investigation into the pharmaceutical sector and the industry has been bracing for separate sectoral tariffs. President Donald Trump said earlier this month, before negotiating the bilateral deal, that pharmaceutical tariffs could be as high as 200%. Some Wall Street analysts said that they do not expect additional tariffs on the EU as a result of the investigation, but others cautioned that the deal was not yet signed and that several questions remained unanswered. UBS analyst Matthew Weston said that he expects details of the trade deal to include protective measures for EU pharma exports from the U.S. investigation, especially since such measures are being discussed in negotiations with the United Kingdom and Switzerland. ING analyst Diederik Stadig also said that while tariffs on top of the 15% were not expected, even after the conclusion of the national security investigations, nothing is completely clear "until a trade deal is inked." Stadig estimates that these levies could add $13 billion to industry expenses without any mitigation strategies, and some of that could be ultimately borne by the consumer. Bernstein analyst Courtney Breen puts the additional expenses at $19 billion for the industry, but she notes that companies might be able to absorb some of the costs with the measures they have been implementing — such as stockpiling of drug products and new deals with contract researchers. Earlier this month, Sanofi said it will sell a manufacturing facility in New Jersey to Thermo Fisher, where the French drugmaker's therapies will continue to be manufactured. Roche's CEO Thomas Schinecker said last week that the company was increasing its U.S. inventories to avoid any immediate disruption from tariffs. UBS' Weston said that it was not immediately clear which generic drugs were exempted from duties under the deal, but any impact for generic drugmaker Sandoz for this year should mostly be manageable. Shares in pharmaceutical companies Sanofi, Roche and Sandoz Group all closed up between 0.5% and 1% on Monday.

Germany's Merz says he did not expect better EU-US trade deal, German economy will suffer
Germany's Merz says he did not expect better EU-US trade deal, German economy will suffer

Yahoo

time10 minutes ago

  • Yahoo

Germany's Merz says he did not expect better EU-US trade deal, German economy will suffer

BERLIN (Reuters) -German Chancellor Friedrich Merz said on Monday he was not satisfied with the result of trade talks with the United States, but "more simply wasn't achievable" and added the German economy would suffer "significant" damage due to the agreed tariffs. The trade deal announced on Sunday imposes a 15% import tariff on most EU goods - lower than the 30% once threatened by U.S. President Donald Trump but well above initial hopes of a zero-for-zero agreement. The rate almost halves the existing tariff rate on Europe's auto sector, a cornerstone of the German economy, from 27.5%, Merz pointed out. "But I am fully aware that the tariffs that remain — particularly the 15% versus 0% for imports into the EU — pose a serious burden for Germany's export-oriented economy," he told a press conference in Berlin. "I am not satisfied with this result in the sense of: 'This is good.' But I do say that, given the starting point we had with the United States, more simply wasn't achievable," he said. The German chancellor thanked the European Commission for its "tireless negotiations" with its U.S. counterparts, with involvement in particular of the German, French, and Italian governments. "I personally did not expect more than this result," he said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store